blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1979356

EP1979356 - CARBONYLAMINO PYRROLOPYRAZOLES, POTENT KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.07.2014
Database last updated on 01.01.2025
Most recent event   Tooltip15.08.2014Lapse of the patent in a contracting statepublished on 17.09.2014  [2014/38]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[2008/42]
Inventor(s)01 / DONG, Liming
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
02 / GUO, Chuangxing
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
03 / HONG, Yufeng
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
04 / JOHNSON, Mary Catherine
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
05 / KEPHART, Susan Elizabeth
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
06 / LI, Haitao
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
07 / MCALPINE, Indrawan James
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
08 / TIKHE, Jayashree Girish
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
09 / YANG, Anle
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
10 / ZHANG, Junhu
Agouron Pharmaceuticals, Inc. A Pfizer Company
10777 Science Center Drive
San Diego, CA 92121 / US
 [2013/38]
Former [2008/42]01 / DONG, Liming
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
02 / GUO, Chuangxing
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
03 / HONG, Yufeng
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
04 / JOHNSON, Mary Catherine
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
05 / KEPHART, Susan Elizabeth
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
06 / LI, Haitao
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
07 / MCALPINE, Indrawan James
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
08 / TIKHE, Jayashree Girish
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
09 / YANG, Anle
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
10 / ZHANG, Junhu
Agouron Pharmaceuticals, Inc. A Pfizer Company 10777 Science Center Drive
San Diego, CA 92121 / US
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2012/32]
Former [2012/14]Ruddock, Keith Stephen, et al
Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2008/42]Verhorevoort, Kerry Linda
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, CT3 9NJ / GB
Application number, filing date06831731.212.12.2006
[2008/42]
WO2006IB03646
Priority number, dateUS20050753349P21.12.2005         Original published format: US 753349 P
US20060864932P08.11.2006         Original published format: US 864932 P
[2008/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007072153
Date:28.06.2007
Language:EN
[2007/26]
Type: A2 Application without search report 
No.:EP1979356
Date:15.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 28.06.2007 takes the place of the publication of the European patent application.
[2008/42]
Type: B1 Patent specification 
No.:EP1979356
Date:18.09.2013
Language:EN
[2013/38]
Search report(s)International search report - published on:EP25.10.2007
ClassificationIPC:C07D487/04
[2008/42]
CPC:
C07D487/04 (EP,KR,US); A61K31/4162 (KR); A61P13/08 (EP);
A61P17/06 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/42]
Extension statesAL21.07.2008
BA21.07.2008
HR21.07.2008
MK21.07.2008
RS21.07.2008
TitleGerman:CARBONYLAMINOPYRROLOPYRAZOLE, WIRKSAME KINASEHEMMER[2008/42]
English:CARBONYLAMINO PYRROLOPYRAZOLES, POTENT KINASE INHIBITORS[2008/42]
French:CARBONYLAMINOPYRROLOPYRAZOLES, INHIBITEURS PUISSANTS DE KINASE[2008/42]
Entry into regional phase21.07.2008National basic fee paid 
21.07.2008Designation fee(s) paid 
21.07.2008Examination fee paid 
Examination procedure21.07.2008Examination requested  [2008/42]
27.11.2008Despatch of a communication from the examining division (Time limit: M04)
27.03.2009Reply to a communication from the examining division
08.03.2012Despatch of a communication from the examining division (Time limit: M06)
14.09.2012Reply to a communication from the examining division
12.02.2013Cancellation of oral proceeding that was planned for 21.02.2013
21.02.2013Date of oral proceedings (cancelled)
19.03.2013Communication of intention to grant the patent
02.05.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.05.2013Communication of intention to grant the patent
06.08.2013Fee for grant paid
06.08.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.11.2008
Opposition(s)19.06.2014No opposition filed within time limit [2014/35]
Fees paidRenewal fee
05.01.2009Renewal fee patent year 03
04.01.2010Renewal fee patent year 04
03.01.2011Renewal fee patent year 05
02.01.2012Renewal fee patent year 06
02.01.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC18.09.2013
[2014/38]
Cited inInternational search[Y]WO0212242  (PHARMACIA & UPJOHN SPA [IT], et al) [Y] 1-21 * page 1, line 7 - line 23 ** claim 1 *;
 [Y]WO2004056827  (PHARMACIA ITALIA SPA [IT], et al) [Y] 1-21 * page 2, column 5 - column 13 * * claim 1 *;
 [Y]WO2005030776  (VERTEX PHARMA [US], et al) [Y] 1-21 * page 5, paragraph 12 * * claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.